{Reference Type}: Editorial
{Title}: Is 50 mg/day the new standard dose of dasatinib in newly diagnosed patients with chronic myeloid leukemia in chronic phase?
{Author}: Saydan B;Özmen D;Eşkazan AE;
{Journal}: Expert Rev Hematol
{Volume}: 17
{Issue}: 7
{Year}: 2024 Jul 25
{Factor}: 2.819
{DOI}: 10.1080/17474086.2024.2370556